Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles, Nicholas; Myles, Hannah; Clark, Scott R; Bird, Robert; Siskind, Dan.
Aust N Z J Psychiatry
; 51(10): 980-989, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28747065
The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
Clozapine dose for schizophrenia.
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
Clozapine re-challenge under the cover of Filgrastim.
Successful rechallenge with clozapine after treatment associated eosinophilia.
Clozapine Rechallenge After Neutropenia or Leucopenia.
Response to clozapine in a clinically identifiable subtype of schizophrenia.
Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.
Rechallenge Following Clozapine-Associated Eosinophilia: A Case Report and Literature Review.
Effectiveness and safety of rapid clozapine titration in schizophrenia.